Stellate Ganglion Block as Novel Treatment for Heart Failure Patients
1 other identifier
interventional
108
1 country
2
Brief Summary
Stellate Ganglion Block as Novel Treatment for Heart Failure Patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Feb 2024
Shorter than P25 for phase_2
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2023
CompletedStudy Start
First participant enrolled
February 5, 2024
CompletedFirst Posted
Study publicly available on registry
February 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedFebruary 6, 2024
February 1, 2024
11 months
November 17, 2023
February 2, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Change of left ventricular ejection fraction (LVEF).
Change of left ventricular ejection fraction (LVEF).
3 month
Change of NYHA classification.
Change of NYHA classification.
3 month
Secondary Outcomes (4)
Change of 6 minutes walking test.
3 month
Heart failure hospitalization.
3 month
Vascular complications and safety issues.
3 month
Cardiovascular death.
3 month
Study Arms (3)
Narrow QRS complex Heart failure patients
NO INTERVENTIONNarrow QRS complex Heart failure patients with optimal medical treatment.
: Narrow QRS complex Heart failure patients
ACTIVE COMPARATOR: Narrow QRS complex Heart failure patients with optimal medical treatment with stellate ganglion block.
Wide QRS complex heart failure patients
ACTIVE COMPARATORWide QRS complex heart failure patients with optimal medical treatment who were non responders to CRT( retrospective and prospective) with stellate ganglion block.
Interventions
A stellate ganglion block is performed by a medical professional in a sterile setting. Firstly Position of patient: Semi-lateral decubitus position, with the neck turned contralateral. Using Probe of ultrasound: Linear 6-13 MHz to guide the needle to the stellate ganglion , The skin at the injection site is cleaned with an antiseptic solution to reduce the risk of infection. A local anesthetic is injected into the skin and deeper tissues to numb the area. Needle:25G 1.5 inch or 22G 3.5 inch is inserted through the skin and deeper tissues until it reaches the stellate ganglion.Once the needle is in the correct position, 3-5 mL of local anesthetic (0.25-0.5% bupivacaine) The procedure typically takes about 15-20 minutes.
Eligibility Criteria
You may qualify if:
- Age 18 : 70 years old.
- NYHA Class III-IV Heart Failure.
- Heart failure with a reduced ejection fraction (HFrEF) LVEF ≤ 40% calculated using 2D echocardiography and Biplane Simpson's .
- Optimal tolerated Medical Therapy for Heart Failure.
You may not qualify if:
- Active Malignancy.
- Acute heart failure including pulmonary edema or cardiogenic shock.
- Severe, life-threatening non-cardiac disease.
- Pregnancy.
- Localized infection.
- Coagulopathy or anticoagulated patients.
- Refused this procedure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Assiut University
Asyut, 71515, Egypt
Assiut university
Asyut, 71515, Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- resident doctor
Study Record Dates
First Submitted
November 17, 2023
First Posted
February 6, 2024
Study Start
February 5, 2024
Primary Completion
January 1, 2025
Study Completion
January 1, 2025
Last Updated
February 6, 2024
Record last verified: 2024-02